CorMedix (CRMD) Amortizatization of Intangibles (2012 - 2019)

CorMedix (CRMD) reported Amortizatization of Intangibles of $84000.0 for Q3 2019, down 26.67% sequentially from $114547.0 in Q2 2019.

CorMedix (CRMD) Amortizatization of Intangibles (2012 - 2019) Analysis & Trends

CorMedix (CRMD) has 3 years of Amortizatization of Intangibles data on file, last reported at $84000.0 in Q3 2019.

For the quarter ending Q3 2019, Amortizatization of Intangibles changed N/A year-over-year to $84000.0; the trailing twelve-month figure through Dec 2019 stood at $313095.0 (changed N/A YoY), and the FY2019 full-year result was $313097.0, down 75.38% from the prior year.
Amortizatization of Intangibles declined to $84000.0 in Q3 2019, from $114547.0 in the prior quarter.
In the past five years, Amortizatization of Intangibles ranged from a high of $114548.0 in Q1 2019 to a low of $84000.0 in Q3 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Amortizatization of Intangibles (Qtr)
1	Oculis Holding AG	66,621.14 Bn	66,620.85 Bn	-	-
2	Nanobiotix	1,915.18 Bn	1,915.11 Bn	-	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-
4	BeOne Medicines	471.27 Bn	466.48 Bn	1.35 Bn	-
5	Vertex Pharmaceuticals	121.81 Bn	114.57 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	69.58 Bn	60.82 Bn	3.31 Bn	-
7	Belite Bio	62.72 Bn	62.72 Bn	-	-
8	Argenx Se	55.51 Bn	50.33 Bn	1.41 Bn	-
9	Revolution Medicines	37.35 Bn	37.35 Bn	-	3.22 Mn
10	CorMedix	4.95 Mn	-150.26 Mn	107.31 Mn	-

Download Data